Anne M. Noonan

3.7k total citations
117 papers, 2.1k citations indexed

About

Anne M. Noonan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Anne M. Noonan has authored 117 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Anne M. Noonan's work include Pancreatic and Hepatic Oncology Research (26 papers), Colorectal Cancer Treatments and Studies (19 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Anne M. Noonan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (26 papers), Colorectal Cancer Treatments and Studies (19 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Anne M. Noonan collaborates with scholars based in United States, Australia and United Kingdom. Anne M. Noonan's co-authors include Christina M. Annunziata, Tanios Bekaii‐Saab, Allan Tsung, Sameh Mikhail, Elise C. Kohn, Daniel H. Ahn, Terence M. Williams, Christina Wu, John L. Hays and Kristen K. Ciombor and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Anne M. Noonan

112 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne M. Noonan United States	27	1.3k	561	396	360	354	117	2.1k
Erika Cecchin Italy	27	1.5k 1.2×	1.2k 2.1×	406 1.0×	363 1.0×	204 0.6×	125	2.6k
Stefania Napolitano Italy	26	1.3k 1.1×	741 1.3×	581 1.5×	520 1.4×	244 0.7×	104	2.2k
Eric T. Kimchi United States	27	1.1k 0.8×	588 1.0×	504 1.3×	382 1.1×	332 0.9×	103	2.1k
Nancy Lewis United States	29	1.5k 1.2×	875 1.6×	811 2.0×	354 1.0×	516 1.5×	62	2.9k
Giuseppe Cicero Italy	28	1.5k 1.2×	762 1.4×	527 1.3×	547 1.5×	892 2.5×	97	2.8k
Ruth Vera Spain	24	1.3k 1.0×	252 0.4×	394 1.0×	283 0.8×	347 1.0×	102	1.8k
Stephen Welch Canada	24	1.0k 0.8×	626 1.1×	388 1.0×	279 0.8×	96 0.3×	124	1.9k
Young H. Kim United States	29	919 0.7×	547 1.0×	525 1.3×	222 0.6×	898 2.5×	77	2.5k
John Mandeli United States	24	659 0.5×	608 1.1×	310 0.8×	323 0.9×	322 0.9×	82	2.2k
Katherine C. Fuh United States	25	669 0.5×	537 1.0×	297 0.8×	278 0.8×	487 1.4×	114	2.0k

Countries citing papers authored by Anne M. Noonan

Since Specialization

Citations

This map shows the geographic impact of Anne M. Noonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Noonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Noonan more than expected).

Fields of papers citing papers by Anne M. Noonan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Noonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Noonan. The network helps show where Anne M. Noonan may publish in the future.

Co-authorship network of co-authors of Anne M. Noonan

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Noonan. A scholar is included among the top collaborators of Anne M. Noonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Noonan. Anne M. Noonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamilton, Ashley, Robin Kate Kelley, Daneng Li, et al.. (2024). ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 42(16_suppl). TPS2675–TPS2675. 2 indexed citations

Raedt, Sepp de, et al.. (2024). Clinical validation of Histotype Px Colorectal in patients in a U.S. colon cancer cohort.. Journal of Clinical Oncology. 42(16_suppl). 3622–3622. 2 indexed citations

Ah, Diane Von, Erin Stevens, Ashley Rosko, et al.. (2024). Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors. Cancers. 16(15). 2718–2718. 2 indexed citations

Han, Claire J., et al.. (2024). Racial/Ethnic Disparities in HRQoL and Associated Risk Factors in Colorectal Cancer Survivors: With a Focus on Social Determinants of Health (SDOH). Journal of Gastrointestinal Cancer. 55(3). 1179–1189. 2 indexed citations

Krishna, Somashekar G., Zarine K. Shah, Phil A. Hart, et al.. (2024). Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol. Pancreatology. 24(2). 289–297. 3 indexed citations

Iyer, Renuka, Anne M. Noonan, Benjamin Spieler, et al.. (2024). EMERALD-Y90: A Phase 2 Study to Evaluate Transarterial Radioembolization Followed by Durvalumab and Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma Eligible for Embolization. International Journal of Radiation Oncology*Biology*Physics. 120(2). e487–e487. 4 indexed citations

Madison, Annelise A., Megan E. Renna, Rebecca Andridge, et al.. (2023). Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases. Pain. 164(9). 1985–1994. 5 indexed citations

Han, Claire J., et al.. (2023). Risk Factors of Health-Related Quality of Life among Gastrointestinal Cancer Survivors in the U.S.: With a Focus on Social and Behavioral Determinants of Health (SBDH). International Journal of Environmental Research and Public Health. 20(17). 6676–6676. 7 indexed citations

Han, Claire J., Leorey N. Saligan, Matthew F. Kalady, et al.. (2023). Latent class symptom profiles of colorectal cancer survivors with cancer-related cognitive impairment. Supportive Care in Cancer. 31(10). 559–559. 7 indexed citations

10.

Gumpper, Kristyn, Phil A. Hart, Martha A. Belury, et al.. (2022). Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer. Cells. 11(5). 910–910. 7 indexed citations

11.

Sebastian, Nikhil, Amy Webb, Kenneth W. Merrell, et al.. (2021). Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma. Cancers. 13(20). 5168–5168. 1 indexed citations

12.

Choueiry, Fouad, Reena Shakya, Brooke Benner, et al.. (2020). CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal for ImmunoTherapy of Cancer. 8(1). e000189–e000189. 61 indexed citations

13.

Wani, Nissar Ahmad, Li Ding, Peng Hu, et al.. (2019). Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma. Molecular Cancer Therapeutics. 19(2). 384–396. 27 indexed citations

14.

Reardon, Joshua, et al.. (2019). Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience. Medical Oncology. 36(10). 87–87. 16 indexed citations

15.

Bekaii‐Saab, Tanios, Alexander Starodub, Bassel F. El‐Rayes, et al.. (2017). A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts). Annals of Oncology. 28. iii150–iii150. 3 indexed citations

16.

Farren, Matthew R., Thomas A. Mace, Susan Geyer, et al.. (2015). Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research. 22(10). 2565–2574. 69 indexed citations

17.

Mikhail, Sameh, Kristen K. Ciombor, Anne M. Noonan, et al.. (2015). Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?. Oncotarget. 6(26). 22206–22213. 5 indexed citations

18.

Noonan, Anne M., David J. Liewehr, Tristan M. Sissung, et al.. (2013). Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel. Clinical Cancer Research. 19(11). 3095–3104. 39 indexed citations

19.

Hsu, Sarah, Lídia Hernandez, Anne M. Noonan, et al.. (2012). IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer. Cancer Research. 72(21). 5494–5504. 43 indexed citations

20.

Lee, Jung Min, John L. Hays, Anne M. Noonan, et al.. (2012). Feasibility and safety of sequential research‐related tumor core biopsies in clinical trials. Cancer. 119(7). 1357–1364. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact